T1 mapping in ischaemic heart disease | Zendy

Darach O h-Icí | Zendy; Sarah Jeuthe | Zendy; Nadya AlWakeel | Zendy; Felix Berger | Zendy; Titus Küehne | Zendy; Sebastian Kozerke | Zendy; Daniel Messroghli | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

T1 mapping in ischaemic heart disease

Author(s) -

Darach O h-Icí,

Sarah Jeuthe,

Nadya AlWakeel,

Felix Berger,

Titus Küehne,

Sebastian Kozerke,

Daniel Messroghli

Publication year - 2014

Publication title -

european heart journal - cardiovascular imaging

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 2.576

H-Index - 92

eISSN - 2047-2412

pISSN - 2047-2404

DOI - 10.1093/ehjci/jeu024

Subject(s) - ischaemic heart disease , myocardial infarction , disease , cardiology , heart disease , medicine , cardiac magnetic resonance , magnetic resonance imaging , radiology

A unique feature of cardiac magnetic resonance is its ability to characterize myocardium. Proton relaxation times, T1, T2, and T2* are a reflection of the composition of individual tissues, and change in the presence of disease. Research into T1 mapping has largely been focused in the study of cardiomyopathies, but T1 mapping also shows huge potential in the study of ischaemic heart disease. In fact, the first cardiac T1 maps were used to characterize myocardial infarction. Robust high-resolution myocardial T1 mapping is now available for use as a clinical tool. This quantitative technique is simple to perform and analyse, minimally subjective, and highly reproducible. This review aims to summarize the present state of research on the topic, and to show the clinical potential of this method to aid the diagnosis and treatment of patients with ischaemic heart disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research